• 1
    Dieppe P, Chard JA, Faulkner A, Lohmander S. Osteoarthritis. In: BartonS, editor. Clinical evidence. London: BMJ Publishing Group; 2000. p. 64963.
  • 2
    Rao JK, Mihaliak K, Kroenke K, Bradley J, Tierney WM, Weinberger M. Use of complementary therapies for arthritis among patients of rheumatologists. Ann Intern Med 1999; 131: 40916.
  • 3
    Reginster JY, Deroisy R, Rovati LC, Lee RL, Lejeune E, Bruyere O, et al. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. Lancet 2001; 357: 2516.
  • 4
    McAlindon TE, LaValley MP, Gulin JP, Felson D. Glucosamine and chondrotin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis. JAMA 2000; 283: 146975.
  • 5
    Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, et al. Development of criteria for the classification and reporting of osteoarthritis: classification of osteoarthritis of the knee. Arthritis Rheum 1986; 29: 103949.
  • 6
    Dieppe PA, Cushnaghan J, Shepstone L. The Bristol 'OA500' study: progression of osteoarthritis (OA) over 3 years and the relationship between clinical and radiographic changes at the knee joint. Osteoarthritis Cartilage 1997; 5: 8797.
  • 7
    Mazzuca SA, Brandt KD, Dieppe PA, Doherty M, Katz BP, Lane KA. Effect of alignment of the medial tibial plateau and x-ray beam on apparent progression of osteoarthritis in the standing anteroposterior knee radiograph. Arthritis Rheum 2001; 44: 178694.
  • 8
    Chard JA, Dieppe PA. Glucosamine for osteoarthritis: magic, hype, or confusion? BMJ 2001; 322: 143940.
  • 9
    Towheed T, Anastassiades TP, Shea B, Houpt JB, Welch V, Hochberg M. Glucosamine therapy for treating osteoarthritis. Cochrane Review 2001.
  • 10
    Fransen M, Crosbie J, Edmonds J. Physical therapy is effective for patients with osteoarthritis of the knee: a randomized controlled clinical trial. J Rheumatol 2001; 28: 15664.
  • 11
    Pendleton A, Arden N, Dougados M, Doherty M, Bannwarth B, Bijlsma JWJ, et al. EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 2000; 59: 93644.
  • 12
    Van Baar ME, Assendelft WJ, Dekker J, Oostendorp RAB, Bijlsma JWJ. Effectiveness of exercise therapy in patients with osteoarthritis of the hip or knee: a systematic review of randomized clinical trials. Arthritis Rheum 1999; 42: 13619.
  • 13
    Juni P, Altman DG, Egger M. Systematic reviews in health care. BMJ 2001; 323: 426.
  • 14
    Campbell R, Evans M, Tucker M, Quilty B, Dieppe P, Donovan JL. Why don't patients do their exercises? Understanding non-compliance with physiotherapy in patients with osteoarthritis of the knee. J Epidemiol Community Health 2001; 55: 1328.
  • 15
    Van Baar ME, Dekker J, Oostendorp RAB, Voorn TB, Bijlsma JWJ. Effectiveness of exercise in patients with osteoarthritis of hip or knee: nine months' follow up. Ann Rheum Dis 2001; 60: 112330.
  • 16
    Yocum D, Fleischmann R, Dalgin P, Caldwell J, Hall D, Roszko P. Safety and efficacy of meloxicam in the treatment of osteoarthritis: a 12-week, double-blind, multi-dose, placebo-controlled trial. Arch Intern Med 2000; 160: 294754.
  • 17
    Mukherjee D, Nissen SE, Topol EJ. Risk of cardiovascular events associated with selective COX-2 inhibitors. JAMA 2001; 286: 9549.
  • 18
    Burnakis TG. Cardiovascular events and COX-2 inhibitors. JAMA 2001; 286: 2808.
  • 19
    Kohler L, Zeidler H, Merkesdal S, Kuipers JG. Safety of celecoxib vs other nonsteroidal anti-inflammatory drugs. JAMA 2000; 284: 3123.
  • 20
    Juni P, Rutjes AWS, Dieppe PA. Are selective COX-2 inhibitors superior to traditional non-steroidal antiinflammatory drugs? BMJ 2002; 324: 12878.
  • 21
    Brandt K, Smith GN Jr, Simon LS. Intraarticular injection of hyaluronan as treatment for knee osteoarthritis: what is the evidence? Arthritis Rheum 2000; 43: 1192203.
  • 22
    Altman RD, Moskowitz R. Intraarticular sodium hyaluronate (Hyalgan®) in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial. J Rheumatol 1998; 25: 220312.
  • 23
    Lohmander LS, Dalen N, Englund G, Hamalainen M, Jensen EM, Karlsson K, et al. Intra-articular hyaluronan injections in the treatment of osteoarthritis of the knee: a randomised, double blind, placebo controlled multicentre trial. Ann Rheum Dis 1996; 55: 42431.
  • 24
    Evanich JD, Evanich CJ, Wright MB, Rydlewicz JA. Efficacy of intraarticular hyaluronic acid injections in knee osteoarthritis. Clin Orthop 2001; 390: 173-81.
  • 25
    Barlow JH, Turner AP, Wright CC. A randomized controlled study of the Arthritis Self-Management Programme in the UK. Health Educ Res 2000; 15: 66580.
  • 26
    Hopman-Rock M, Westhoff MH. The effects of a health educational and exercise program for older adults with osteoarthritis of the hip or knee. J Rheumatol 2000; 27: 194754.
  • 27
    Tallon D, Chard JA, Dieppe PA. Relation between agendas of the research community and the research consumer. Lancet 2000; 355: 203740.
  • 28
    Hawker GA, Wright JG, Coyte PC, Williams JI, Harvey B, Glazier R, et al. Differences between men and women in the rate of use of hip and knee arthroplasty. N Engl J Med 2000; 342: 101622.
  • 29
    Hajat S, Fitzpatrick R, Morris R, Reeves B, Rigge M, Williams O, et al. Does waiting for total hip replacement matter? Prospective cohort study. J Health Serv Res Policy 2002; 7: 1925.